scholarly article | Q13442814 |
P50 | author | Yunfei Yuan | Q40548428 |
Shi-Mei Zhuang | Q63647398 | ||
Hang Su | Q80931286 | ||
P2093 | author name string | Jing Zhao | |
Ying Zhang | |||
Teng Xu | |||
Fan Zhou | |||
Yujuan Xiong | |||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 27-35 | |
P577 | publication date | 2008-02-14 | |
P1433 | published in | Mutation Research | Q6943732 |
P1476 | title | Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China | |
P478 | volume | 641 |
Q40707010 | "Testing your methyl": DNA methylation profiling of serum DNA of HCC patients. |
Q36134242 | Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma |
Q36092123 | Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis |
Q38339878 | Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma. |
Q38254776 | Effects of Mutations of 3 Amino Acids on Hepatocellular Carcinoma: A Systematic Review and Meta-analysis |
Q36698843 | Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma. |
Q28385295 | Environmental toxicants, epigenetics, and cancer |
Q38692795 | Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises |
Q63349138 | Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma |
Q41700141 | Genetic variations in the one-carbon metabolism pathway genes and susceptibility to hepatocellular carcinoma risk: a case-control study |
Q35899166 | Genome-wide DNA methylation profiles in hepatocellular carcinoma. |
Q35606904 | Hepatitis B virus infection and the risk of hepatocellular carcinoma |
Q26851211 | Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development |
Q42040454 | Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma |
Q37496567 | Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients |
Q34450660 | Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma |
Q36945012 | Relation between microRNAs and Apoptosis in Hepatocellular Carcinoma |
Q37584718 | TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis |
Q34152847 | Therapeutics Based on microRNA: A New Approach for Liver Cancer |
Q41933719 | p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA). |
Search more.